6 insider filings
Elizabeth Stoner, insider filing for IBIO
Show all 6
- 4Insider filing for IBIO
- 4Insider filing for IBIO
- 4Insider filing for IBIO
- 4Insider filing for IBIO
- 4Insider filing for IBIO
- 4Insider filing for IBIO
Elizabeth Stoner, reporting
IBIO
iBio, Inc. SEC filings
Every EDGAR filing for iBio, Inc. (IBIO), newest first, with AI summaries and stories.
- Ticker
- IBIO
- CIK
- 1420720
- Sector
- Biotech and pharma
- Latest filing
- 3d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4iBio, Inc.IBIOLIVE ROUTINESCHEDULE 13GiBio, Inc.IBIOLIVE iBio, Inc. shares held by Coastlands Capital LP
- Coastlands Capital LP filed a Schedule 13G on 2026-10-14.
- Owns 6,247,738 shares of iBio, Inc. common stock.
- Represents 9.72% of the company's outstanding shares.
Coastlands Capital LP, filed by
ROUTINE8-KiBio, Inc.IBIOLIVE iBio reports positive preclinical data for IBIO-610
- Preclinical study showed 93% fat loss with IBIO-610 and semaglutide
- IBIO-610 inhibited 97% of active Activin E in NHPs
- First-in-human trials planned for 2027
ROUTINE8-KiBio, Inc.IBIOLIVE ROUTINEARSiBio, Inc.IBIOLIVE ROUTINEDEF 14AiBio, Inc.IBIOLIVE ROUTINE8-KiBio, Inc.IBIOLIVE NOTABLE10-KiBio, Inc.IBIOLIVE ROUTINEPRE 14AiBio, Inc.IBIOLIVE ROUTINESCHEDULE 13GiBio, Inc.IBIOLIVE 2 13G filings
Ownership stake disclosure by Lynx1 Capital Management LP
Show all 2
- SCHEDULE 13GOwnership stake disclosure
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Lynx1 Capital Management LP, filed by
ROUTINESCHEDULE 13G/AiBio, Inc.IBIOLIVE Ownership stake disclosure by Cormorant Asset Management, LP (amended)
Cormorant Asset Management, LP, filed by
ROUTINESCHEDULE 13G/AiBio, Inc.IBIOLIVE Ownership stake disclosure by Affinity Asset Advisors, LLC (amended)
Affinity Asset Advisors, LLC, filed by
ROUTINE4iBio, Inc.IBIOLIVE Molly Carr, insider filing for IBIO
Molly Carr, reporting
ROUTINE3iBio, Inc.IBIOLIVE Molly Carr, new insider at IBIO
Molly Carr, reporting
ROUTINE8-KiBio, Inc.IBIOLIVE ROUTINE8-KiBio, Inc.IBIOLIVE ROUTINE8-KiBio, Inc.IBIOLIVE ROUTINE4iBio, Inc.IBIOLIVE Elizabeth Stoner, insider filing for IBIO
Elizabeth Stoner, reporting
ROUTINESCHEDULE 13G/AiBio, Inc.IBIOLIVE Ownership stake disclosure by Logos Global Management LP (amended)
Logos Global Management LP, filed by
ROUTINESCHEDULE 13G/AiBio, Inc.IBIOLIVE Ownership stake disclosure by Point72 Asset Management, L.P. (amended)
Point72 Asset Management, L.P., filed by
ROUTINESCHEDULE 13G/AiBio, Inc.IBIOLIVE Ownership stake disclosure by EcoR1 Capital, LLC (amended)
EcoR1 Capital, LLC, filed by
ROUTINESCHEDULE 13G/AiBio, Inc.IBIOLIVE Ownership stake disclosure by Cormorant Asset Management, LP (amended)
Cormorant Asset Management, LP, filed by
ROUTINESCHEDULE 13GiBio, Inc.IBIOLIVE Ownership stake disclosure by Sirenia Capital Management LP
Sirenia Capital Management LP, filed by
ROUTINE3iBio, Inc.IBIOLIVE Elizabeth Stoner, new insider at IBIO
Elizabeth Stoner, reporting
ROUTINESCHEDULE 13G/AiBio, Inc.IBIOLIVE Ownership stake disclosure by Affinity Asset Advisors, LLC (amended)
Affinity Asset Advisors, LLC, filed by
ROUTINESCHEDULE 13G/AiBio, Inc.IBIOLIVE Ownership stake disclosure by Frazier Life Sciences Public Fund, L.P. (amended)
Frazier Life Sciences Public Fund, L.P., filed by
NOTABLE10-QiBio, Inc.IBIOLIVE ROUTINE8-KiBio, Inc.IBIOLIVE ROUTINE8-KiBio, Inc.IBIOLIVE ROUTINE424B3iBio, Inc.IBIOLIVE ROUTINE8-K/AiBio, Inc.IBIOLIVE ROUTINE8-KiBio, Inc.IBIOLIVE ROUTINE4iBio, Inc.IBIOLIVE Marc Banjak, insider filing for IBIO
Marc Banjak, reporting
ROUTINE4iBio, Inc.IBIOLIVE 2 insider filings
Felipe Duran, insider filing for IBIO
Show all 2
- 4Insider filing for IBIO
- 4Insider filing for IBIO
Felipe Duran, reporting
ROUTINE8-KiBio, Inc.IBIOLIVE ROUTINEEFFECTiBio, Inc.IBIOLIVE ROUTINE424B5iBio, Inc.IBIOLIVE ROUTINE8-KiBio, Inc.IBIOLIVE ROUTINES-3iBio, Inc.IBIOLIVE ROUTINESCHEDULE 13G/AiBio, Inc.IBIOLIVE 2 13G filings
Ownership stake disclosure by ADAR1 Capital Management, LLC (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
ADAR1 Capital Management, LLC, filed by
ROUTINESCHEDULE 13G/AiBio, Inc.IBIOLIVE Ownership stake disclosure by Lynx1 Capital Management LP (amended)
Lynx1 Capital Management LP, filed by
NOTABLE10-QiBio, Inc.IBIOLIVE